文献速递细菌感染、耐药与抗菌药物

芬兰2008-16年儿童和青少年门诊抗菌药物使用与费用全国登记研究

Outpatient antibacterial use and costs in children and adolescents: a nationwide register-based study in Finland, 2008-16.
PubMed 文献 · J Antimicrob Chemother · 2019-01-01

该研究基于芬兰处方登记数据库,分析了2008-16年0-17岁儿童和青少年门诊系统性抗菌药物的使用率和费用。结果显示抗菌药物处方总体使用率下降,2010年最高为每1000名儿童708张处方,2016年最低为374张;1-2岁儿童使用率最高,男孩略高于女孩。常用前10种抗菌药物占约97%的处方,广谱青霉素最常用。总费用下降但每张处方费用上升。

要点

  • 抗菌药物处方总体使用率下降,2010年最高708/1000儿童,2016年最低374/1000。
  • 1-2岁儿童抗菌药物使用率最高,男孩略高于女孩。
  • 总费用下降但每张处方费用上升,可能因部分口服溶液失去报销资格。

核心结论

  • 芬兰儿童和青少年门诊抗菌药物处方使用率在2008-16年间呈下降趋势,与年龄和性别无关。
  • 总抗菌药物费用下降,但每张处方费用增加,可能因部分抗菌药物口服溶液失去报销资格给家庭带来额外经济负担。

研究设计与样本

  • 基于芬兰处方登记数据库的全国登记研究,纳入2008-16年0-17岁儿童和青少年门诊系统性抗菌药物报销处方数据。

主要发现

  • 抗菌药物处方总体使用率从2010年每1000名儿童708张降至2016年374张。
  • 1-2岁儿童抗菌药物处方使用率最高,男孩使用率略高于女孩。
  • 最常用的10种抗菌药物占所有处方的约97%,广谱青霉素最常用。
  • 研究期间抗菌药物总费用下降,但每张处方费用上升。

临床怎么用

  • 关注儿童抗菌药物使用趋势,尤其是1-2岁高使用率人群。
  • 报销政策变化可能影响抗菌药物使用和家庭经济负担,需综合评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe the prevalence of outpatient use and the costs of systemic antibacterials among children and adolescents in Finland during 2008-16 and to examine patterns of use by age and gender. METHODS: Data were retrieved from the Finnish statistical database Kelasto, based on the Finnish Prescription Registry. Data included information on dispensed reimbursed prescriptions of antibacterials for systemic use in children aged 0-17 years during 2008-16. The prevalence of antibacterial prescriptions per 1000 children and costs per prescription were calculated. RESULTS: The overall prevalence of antibacterial prescriptions decreased in the study period and was highest in 2010 (with 708 prescriptions per 1000 children) and lowest in 2016 (with 374 prescriptions per 1000 children). Children aged 1-2 years had the highest prevalence of antibacterial prescriptions. Furthermore, boys had slightly higher prevalences than girls. The 10 most commonly used antibacterial agents covered ∼97% of all prescriptions and broad-spectrum penicillins were the most commonly used antibacterials. The total costs of antibacterials decreased during the study period, but the costs per prescription increased. CONCLUSIONS: This study showed a decreasing trend in the prescribing of antibacterial drugs, regardless of age or gender. Increasing awareness of antimicrobial resistance, reimbursement status changes and pneumococcal and influenza vaccinations are possible reasons for this. Some of the antibacterial oral solutions lost their reimbursement status, but their consumption did not decrease any faster than the consumption of the substances with continuous reimbursability. It is likely that removing the reimbursement status of antibacterials has placed an extra cost burden on families and increased costs per prescription.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Parviainen S, Saastamoinen L, Lauhio A, et al. Outpatient antibacterial use and costs in children and adolescents: a nationwide register-based study in Finland, 2008-16. J Antimicrob Chemother. 2019. PMID: 31102531. doi:10.1093/jac/dkz208

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。